Some of the nation’s top colleges are eliminating student loans
More colleges are promising to eliminate student loans altogether from their financial aid packages.
Elon Musk’s X illegally fired employee who publicly challenged return-to-work plans, NLRB alleges
The National Labor Relations Board filed a complaint on Friday against Elon Musk’s X, claiming the company violated the National Labor Relations Act.
Why Meta, X and TikTok face more pressure from Europe than the U.S. on Israel-Hamas war disinformation
The European Union enacted the Digital Services Act, which requires very large online platforms to mitigate the risk of disinformation.
‘There is nowhere to hide from the bombs’: Civilians trapped in Gaza can’t escape Israel’s siege
In the Gaza Strip survival is increasingly a game of chance.
What to make of the UAW’s shifting strike tactics after the latest escalation
The union initiated a surprise strike of 8,700 workers at Ford Motor’s Kentucky Truck Plant, the most crucial plant affected by the disruptions so far.
Pharmacy staff from Walgreens, other chains could stage nationwide walkout and rallies in coming weeks
The plans come after separate walkouts staged by pharmacy staff from CVS stores in the Kansas City area and Walgreens locations around the country.
Biden praises Kaiser Permanente labor agreement after worker strike: ‘Collective bargaining works’
The Biden administration helped broker a deal between more than 85,000 health workers and Kaiser Permanente.
Regional banks are in focus in the week ahead as third-quarter earnings season ramps up
Regional bank earnings are expected to be a weak point this earnings season.
New RSV protections for infants hit cost, insurance hurdles in U.S. rollout
Pfizer’s maternal vaccine, Abrysvo, and Sanofi’s monoclonal antibody, Beyfortus, were approved for expectant mothers and infants in the U.S. earlier this year.
This European biotech company could rally nearly 45%, says Morgan Stanley
Morgan Stanley is bullish on pelabresib, currently awaiting results from its Phase 3 MANIFEST-2 trial.
